Granisetron transdermal (Sancuso)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Granisetron transdermal (Sancuso), covering 2021-05-17 to 2021-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation [Phase 3]